Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

被引：0
|
作者：
Anne Bertrand
Marie Kostine
Thomas Barnetche
Marie-Elise Truchetet
Thierry Schaeverbeke
机构：
[1] Département de Rhumatologie,Laboratoire d’Immunologie, UMR
[2] Hôpital Pellegrin,CNRS 5164
[3] CHU de Bordeaux,Unité sous Contrat, Infections à Mycoplasmes et à Chlamydia chez l’Homme
[4] Université de Bordeaux,undefined
[5] Université de Bordeaux,undefined
来源：
BMC Medicine | / 13卷
关键词：
Anti-CTLA4 antibodies; Colitis; Dermatitis; Hypohysitis; Immune related adverse events; Ipilimumab; Metastatic tumors; Oncology; Tremelimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Association among major adverse cardiovascular events with immune checkpoint inhibitors: A systematic review and meta-analysis
    Li, Haixia
    Zheng, Yanfei
    Li, Bin
    Zhi, Yinghao
    Chen, Mingxian
    Zeng, Jing
    Jiao, Qian
    Tao, Yuxuan
    Liu, Xinmei
    Shen, Zican
    Zhang, Jiahui
    Zhao, Weizhe
    Chen, Dong
    JOURNAL OF INTERNAL MEDICINE, 2025, 297 (01) : 36 - 46
  • [42] A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma
    Wang, Bengang
    Hao, Xiangjun
    Yan, Jinshan
    Li, Xin
    Zhao, Mingfang
    Han, Tao
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2024, 12 (03) : 225 - 243
  • [43] Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
    Zhang, Shuo
    Zhou, Ziyue
    Wang, Li
    Li, Mengtao
    Zhang, Fengchun
    Zeng, Xiaofeng
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [44] Gastrointestinal treatment-related adverse events of combined immune checkpoint inhibitors: a meta-analysis
    Karna, Rahul
    S Deliwala, Smit
    Ramgopal, Balasubramanian
    Asawa, Palash
    Mishra, Rahul
    P Mohan, Babu
    Jayakrishnan, Thejus
    Grover, Dheera
    Kalra, Tanisha
    Bhalla, Jaideep
    Saraswati, Ushasi
    Gangwani, Manesh K.
    Dhawan, Manish
    Adler, Douglas G.
    IMMUNOTHERAPY, 2023, 15 (10) : 773 - 786
  • [45] The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis
    Xu, Huilin
    Xu, Ximing
    Ge, Wei
    Lei, Jinju
    Cao, Dedong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [46] Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Zhang, Wei
    Tan, Yifei
    Li, Yuquan
    Liu, Jiang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials
    Hao, Chunyan
    Tian, Jinhui
    Liu, Huiling
    Li, Fei
    Niu, Hongxia
    Zhu, Bingdong
    MEDICINE, 2017, 96 (26)
  • [48] Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
    Zhao, Qing
    Zhang, Jianwei
    Xu, Lingyi
    Yang, Huaxia
    Liang, Naixin
    Zhang, Li
    Zhang, Fengchun
    Zhang, Xuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis
    Hu, Jiexuan
    Tian, Ruyue
    Ma, Yingjie
    Zhen, Hongchao
    Ma, Xiao
    Su, Qiang
    Cao, Bangwei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies Systematic review
    Johansen, Annette
    Christensen, Soren Just
    Scheie, David
    Hojgaard, Joan L. S.
    Kondziella, Daniel
    NEUROLOGY, 2019, 92 (14) : 663 - 674
12345